Efficacy and safety of umbilical cord-derived mesenchymal stem cells in chinese adults with type 2 diabetes: a single-center, double-blinded, randomized, placebo-controlled phase ii trial

HIGHLIGHTS

• who: Li Zang from the Department of Endocrinology, The First Medical Center of Chinese PLA General Hospital, No, Fuxing Road, Beijing, China have published the research: Efficacy and safety of umbilical cord-derived mesenchymal stem cells in Chinese adults with type 2 diabetes: a single-center, double-blinded, randomized, placebo-controlled phase II trial, in the Journal: (JOURNAL)
• what: The authors demonstrated that UC-MSCs infusion significantly alleviated insulin resistance in a time-dependent manner, which indicated that UC-MSCs treatment was effective at improving insulin resistance in T2DM. In the study , one patient suffered . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.